Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses
- 3 December 2009
- journal article
- Published by Taylor & Francis Ltd in Journal of Drug Targeting
- Vol. 18 (5), 381-388
- https://doi.org/10.3109/10611860903483396
Abstract
The primary aim of this study was to investigate intranasal (i.n.) administration as a potential route to enhance systemic and brain delivery of didanosine (ddI). A further aim was to investigate the potential use of chitosan nanoparticles as a delivery system to enhance the systemic and brain targeting efficiency of ddI following i.n. administration. Didanosine-loaded chitosan nanoparticles, were prepared through ionotropic gelation of chitosan with tripolyphosphonate anions, and characterized in terms of their size, drug loading, and in vitro release. The nanoparticles were administered i.n. to rats, compared to i.n. and intravenous (i.v.) administration of ddI in solution. The concentrations of ddI in blood, CSF, and brain tissues were analyzed by ultra performance liquid chromatography mass spectroscopy (UPLC/MS). The brain/plasma, olfactory bulb/plasma and CSF/plasma concentration ratios were significantly higher (P < 0.05) after i.n. administration of ddI nanoparticles or solution than those after i.v. administration of didanosine aqueous solution. The ratio of ddI concentration values of the nanoparticles to the solution at 180 min post-i.n. dosing was 2.1 and 1.9 in CSF and brain, respectively. Thus, both the i.n. route of administration and formulation of ddI in chitosan nanoparticles increased delivery of ddI to CSF and brain.Keywords
This publication has 21 references indexed in Scilit:
- Targeted brain delivery of 17β-estradiol via nasally administered water soluble prodrugsAAPS PharmSciTech, 2002
- Enhancement of Nasal Absorption of Insulin Using Chitosan NanoparticlesPharmaceutical Research, 1999
- The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous SystemJournal of Pharmacy and Pharmacology, 1996
- Enhanced Oral Bioavailability of DDI After Administration of 6-Cl-ddP, an Adenosine Deaminase-Activated Prodrug, to Chronically Catheterized RatsPharmaceutical Research, 1995
- Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)Pharmaceutical Research, 1994
- Approaches toward the optimization of CNS uptake of anti-AIDS agentsJournal of Controlled Release, 1992
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionThe New England Journal of Medicine, 1991
- Preformulation solubility and kinetic studies of 2',3'-dideoxypurine nucleosides: potential anti-AIDS agentsInternational Journal of Pharmaceutics, 1988
- Mechanism of Nasal Absorption of Drugs I: Physicochemical Parameters Influencing the Rate of In Situ Nasal Absorption of Drugs in RatsJournal of Pharmaceutical Sciences, 1985
- Quantitative studies of the avidity of naturally occurring substances for trace metals. 3. Pteridines, riboflavin and purinesBiochemical Journal, 1953